# Continued Evaluation of Patients With Parkinson's Disease Who Previously Received BRT-DA01

> **NCT05897957** · — · ENROLLING_BY_INVITATION · sponsor: **BlueRock Therapeutics** · enrollment: 12 (estimated)

## Conditions studied

- Parkinson Disease

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT05897957
- **Lead sponsor:** BlueRock Therapeutics
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2023-05-16
- **Primary completion:** 2027-05
- **Final completion:** 2027-09
- **Target enrollment:** 12 (ESTIMATED)
- **Last updated:** 2024-04-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05897957

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05897957, "Continued Evaluation of Patients With Parkinson's Disease Who Previously Received BRT-DA01". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05897957. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*